non-small cell lung carcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: PD-L1 for all specimens of patients with non-small cell lung cancer patients who obtained pleural effusion cell block Yokohama City Municipal Hospital Respiratory Medicine Department in the past 3 years, excluding those refused by the patient, Perform inspection.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immunohistochemical staining of PD-L1 in pleural effusion cell block. | — |
Countries
Japan
Contacts
Yokohama municipal CItizens Hospital Respiratory medicine